大型细胞学良性甲状腺结节恶性率与假阴性率不高,可考虑临床观察:一项Meta分析
结果显示,≥3 cm和≥4 cm结节的总体恶性率分别低于<3 cm和<4 cm结节;≥3 cm结节的细针穿刺假阴性率与小结节无差异,≥4 cm结节假阴性率略高于<4 cm结节。结论认为大型细胞学良性甲状腺结节不必立即手术切除,可考虑临床观察。
要点
- ≥3 cm和≥4 cm结节的总体恶性率分别低于<3 cm和<4 cm结节。
- ≥3 cm结节细针穿刺假阴性率与小结节无差异。
- 大型细胞学良性甲状腺结节不必立即手术,可考虑临床观察。
核心结论
- 大型细胞学良性甲状腺结节的恶性率和假阴性率在多数研究中并不高于小结节,可考虑临床观察而非立即手术切除。
研究设计与样本
- 35篇文章中,分别有14、24和1篇分析了3、4和5 cm的大小截断值。
主要发现
- 所有结节中,≥3 cm结节恶性率为13.1%,低于<3 cm结节的19.6%(OR=0.72,95%CI 0.64-0.81)。
- 所有结节中,≥4 cm结节恶性率为20.9%,低于<4 cm结节的19.9%(OR=0.85,95%CI 0.77-0.95)。
- ≥3 cm结节细针穿刺假阴性率为7.2%,与<3 cm结节的5.7%无差异(OR=1.47,95%CI 0.80-2.69)。
- ≥4 cm结节细针穿刺假阴性率为6.7%,略高于<4 cm结节的4.5%(OR=1.38,95%CI 1.06-1.80)。
- 最常报告的假阴性诊断是甲状腺乳头状癌。
临床怎么用
- 对于细胞学良性的大型甲状腺结节,可考虑临床观察,不必立即手术切除。
- 假阴性率总体较低,且随着甲状腺乳头状癌滤泡亚型命名的修订,预期假阴性率将进一步降低。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: Management of large thyroid nodules is controversial, as data are conflicting regarding overall rates of malignancy (ROM) in all nodules and frequency of false-negative fine-needle aspiration results (FNR) in cytologically benign nodules. This meta-analysis aimed to evaluate and compare ROM and FNR in small versus large nodules published in the literature. Methods: Articles indexed in PubMed, written in English, published electronically or in print on or prior to December 8 2017 were searched for "false negative thyroid size or cm" and "malignancy rates benign thyroid nodules." Three hundred fifty-two unique citations were identified. Multiple reviewers selected a final set of 35 articles that contained nodules stratified by size (3, 4, or 5 cm), with benign or all cytologic diagnoses, and with postsurgical histologic diagnoses. Multiple observers extracted data, including numbers of total, cytologically benign, and histologically malignant nodules. Size cutoffs of 3, 4, and/or 5 cm were analyzed in 14, 24, and 1 article, respectively. Results: ROM in all nodules ≥3 cm (13.1%) and ≥4 cm (20.9%) was lower than those <3 cm (19.6%) and <4 cm (19.9%; odds ratio [OR] = 0.72 [confidence interval (CI) 0.64-0.81] and OR = 0.85 [CI 0.77-0.95]). FNR in nodules ≥3 cm (7.2%) was not different from smaller nodules (5.7%; OR = 1.47 [CI 0.80-2.69]). FNR in nodules ≥4 cm (6.7%) was slightly higher than those <4 cm (4.5%; OR = 1.38 [CI 1.06-1.80]). The most frequently reported false-negative diagnosis was papillary thyroid carcinoma. Conclusions: Rates of malignancy and false-negative FNA results vary but, in most studies, are not higher in larger nodules. Patients with large, cytologically benign thyroid nodules need not undergo immediate surgical resection, as false-negative FNA rates are low and are expected to decrease in light of nomenclature revision of a subset of follicular variants of papillary thyroid carcinoma.
引用
- Cipriani NA, White MG, Angelos P, et al. Large Cytologically Benign Thyroid Nodules Do Not Have High Rates of Malignancy or False-Negative Rates and Clinical Observation Should be Considered: A Meta-Analysis. Thyroid. 2018. PMID: 30280990. doi:10.1089/thy.2018.0221
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。